Search for Cancer Drug may Be Accelerated by 'Lab-on-Bead' Process

by Rajashri on October 11, 2008 at 3:42 PM
 Search for Cancer Drug may Be Accelerated by 'Lab-on-Bead' Process

A nanotechnology called the "Lab-on-Bead" process may hasten and simplify the search for new cancer drugs.

Developed by researchers at Wake Forest University, the process will screen millions of chemicals simultaneously using tiny plastic beads, so small that 1,000 of them can be placed on a single strand of human hair.


Each bead in the process contains a different chemical, which, if turns out to be successful in treating cancer, can be identified later.

A single batch of nanoscopic beads can easily match thousands of conventional, repetitive laboratory tests.

"This process allows the beads to do the work for you. By working at this scale, we will be able to screen more than a billion possible drug candidates per day as opposed to the current limit of hundreds of thousands per day," explained Jed Macosko, project director and assistant professor of physics at Wake Forest.

He further said that they were developing a new device that could automate the Lab-on-Bead process, and permit parallel processing to attain faster screening results.

The researchers are also working with biotechnologists at Harvard University in Boston and Universite Louis Pasteur in Strasbourg, France, which are providing the chemicals being screened for drug candidates.

Source: ANI
Font : A-A+



Recommended Readings

Latest Drug News

Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Apotransferrin's Potential in Early Stroke Therapy Revealed
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
Anti-cancer Drug Navitoclax Help Treat Lower Back Pain
The reduction of these senescent osteoclasts, possibly through the utilization of current medications, could present a novel approach in managing lower back pain.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Search for Cancer Drug may Be Accelerated by 'Lab-on-Bead' Process Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests